3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
9
Breast Neoplasms
8
Lymphoma, Mantle-Cell
7
Leukemia, Myeloid, Acute
7
Leukemia
7
Congenital Abnormalities
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Myeloproliferative Disorders
6
Multiple Myeloma
6
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
5
Burkitt Lymphoma
5
Waldenstrom Macroglobulinemia
4
Myelodysplastic Syndromes
4
Lymphoma, Large-Cell, Immunoblastic
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myeloid, Chronic-Phase
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Sezary Syndrome
3
Mycosis Fungoides
3
Melanoma
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Accelerated Phase
3
Hodgkin Disease
3
Interventions
Fluorouracil
41
Radiotherapy
38
Cisplatin
35
Oxaliplatin
32
Leucovorin
24
Paclitaxel
22
Irinotecan
20
Docetaxel
17
Neoadjuvant Therapy
14
Carboplatin
13
Radiation
12
Capecitabine
12
Surgical Procedures, Operative
10
Cetuximab
8
Biopsy
8
durvalumab
7
Gefitinib
7
Chemotherapy, Adjuvant
7
tremelimumab
6
pembrolizumab
6
Nivolumab
6
Magnetic Resonance Spectroscopy
6
Folfox protocol
6
Taxes
5
Immunohistochemistry
5
Endoscopy
5
Gene Expression Profiling
4
Epirubicin
4
Drug Therapy
4
dehydroftorafur
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adenocarcinoma Of Esophagus
×
In Situ Hybridization, Fluorescence
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled